The Mission of MOASC is to advance and protect the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care.

  • Days

  • Hours

  • Minutes

  • Seconds


Thank you to those who joined us at the MOASC and UC Irvine Health, Division of Hematology/Oncology presentation of, “Spotlight on ASH,”

held Thursday, January 28, 2016,at the Fairmont Hotel in Newport Beach. After the Networking Reception and Exhibit Hall with Program Sponsors, attendees were welcomed by Robert Moss, M.D., Chairman of the Board, Past President, MOASC. Chaitali Nangia, MD. Introduced the MOASC Fellows Grant recipients Monica El-Masry, MD & Bhavana Pathak, MD who spoke on Cardiovascular Disease in Adolescents and Young Adults with Hematologic Malignancies.
– Angela Fleischman, MD, PhD discussed Mutational Landscape of MPN; Emerging JAK Inhibitors; Ruxolitinib Combination Trials; Anti-Fibrotic Agents.
– Deepa Jeyakumar, MD addressed Acute Myeloid Leukemia.
– Kanwar Kahlon, MD presented Chronic Lymphocytic Leukemia.
– Richard Van Etten, MD, PhD discussed Chronic Myeloid Leukemia.

MOASC & UCI would like to thank

Alexion, Amgen, Bristol Myers Squibb, Celgene, Eisai, Gilead Science, Johnson and Johnson, Merck, Sanofi/Genzyme, Tesaro and Pfizer for their support of this program.
Specific Oncology Tube presentations can be accessed through the links above.

See Gallery

Save the Date


Sign Up For Our Newsletter

Receive important news and updates about our organization